APA (7th ed.) Citation

Iinuma, K., Enomoto, T., Kawada, K., Fujimoto, S., Ishida, T., Takagi, K., . . . Koie, T. (2021). Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab. MDPI AG.

Chicago Style (17th ed.) Citation

Iinuma, Koji, et al. Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab. MDPI AG, 2021.

MLA (8th ed.) Citation

Iinuma, Koji, et al. Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab. MDPI AG, 2021.